Free Trial

Cara Therapeutics (CARA) News Today

$0.62
-0.02 (-3.10%)
(As of 06/7/2024 ET)
Cara: Q1 Earnings Snapshot
Cara Porto-Osborn of Young + Wright Architectural
Cara Therapeutics Inc
Demystifying Cara Therapeutics: Insights From 4 Analyst Reviews
CARA Apr 2024 5.000 call
Cara Therapeutics (NASDAQ:CARA) Price Target Cut to $10.00
Canaccord Genuity Group dropped their price target on shares of Cara Therapeutics from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Wednesday.
Get Cara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CARA and its competitors with MarketBeat's FREE daily newsletter.

Breaking - The US Gov. Seized CITGO (Ad)

Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).

Get all the details here.

CARA Media Mentions By Week

CARA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CARA
News Sentiment

0.00

0.73

Average
Medical
News Sentiment

CARA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CARA Articles
This Week

0

2

CARA Articles
Average Week

Get Cara Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CARA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CARA) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners